definiens: means the lease dated 5 May 2000 between ( 1 ) Phar maServ GmbH ( originally PharmaServ GmbH & Co. KG ) and [COMPANY] Vaccines and Diagnostics GmbH ( original contractual party Chiron Behring GmbH & Co. ) in res pect of Building H12 ( amongst others ) at Behringwerke, Emil - von - Behring - Straße 76, 35041 Mar burg, Germany and any other lease(s ) at Marburg ( Germany ) where the premises demised by suc h lease(s ) are occupied in whole or in part by the Flu Group for the manufacture of MF59 ® adjuvant ( the ) ; has the meaning set out in paragraph 1.2.1 of thi s Part 4B of Schedule 3 ; means the person for the time being entitled to t he reversion immediately expectant on the termination of the term granted by a Lease ; means the German Carve - out Leases, including all documents supplemental to them, and means any one of them ; means a date being 15 months after the Closing Da te or such other date as the parties may agree ; means all consents, licences, approvals, permits, authorisations or waivers required from any Landlord, superior landlo rd and/or other third party, including any consents, licences, approvals, permits, authorisations or wai vers required by any legislation or regulation or b y any statutory, governmental, state, provincial or m unicipal bodies or authorities for or in connection with the Separation and includes Sublease Consents and, where appropriate, any consents required in relation to any change of control, shareholders or directors in a Flu Group Company ; has the meaning given to it in paragraph 1.2.1 of this Part 4B of Schedule 3 ; has the meaning given to it in paragraph 1.9.2 of this Part 4B of Schedule 3 ; and, for the purposes of this Part 4B of Schedule 3 o nly, means any tenant under any Lease ; 1.2 Separation of the German Carve - out Lease(s ) 1.2.1 The Seller shall use reasonable endeavours to procu re, subject to paragraph 1.2.5 below, prior to Closing the contemporaneous surrender of the German Carve - out Leases and the grant of replacement leases, certain of which shall relate e xclusively to those parts of the premises demised by the German Carve - out Leases which are us ed by the Flu Group for the manufacture of MF59 ® adjuvant, 98 including where appropriate ( joint ) use of ancillar y parts and common facilities and comprise the Marburg MF59 ® Premises ( the ( the )